The role of the independent clinical laboratory in new assay development and commercialization.
Most would agree that these are exciting times in the field of laboratory medicine. As the body of scientific knowledge expands and research activities, such as those catalyzed by the sequencing of the human genome, bring us closer to the promise of personalized medicine, the clinical laboratory industry will have increasing opportunities to partner with owners of intellectual property to develop and commercialize new diagnostic tests. The large, independent clinical laboratories are particularly well positioned to commercialize important new tests, with their broad market penetration, infrastructure, and the scale to run esoteric tests cost-effectively.
Ellis
David G
DG
Licensing, Laboratory Corporation of America, Research Triangle Park, North Carolina, USA.
D001681:Biological Assay / Q000191:economics / Q000639:trends; D020811:Biomedical Technology / Q000191:economics* / Q000639:trends; D019411:Clinical Laboratory Techniques / Q000639:trends; D003132:Commerce / Q000458:organization & administration*; D006801:Humans; D007753:Laboratories / Q000458:organization & administration*; D008004:Licensure; D010330:Patents as Topic; D017149:Private Sector / Q000191:economics / Q000458:organization & administration*; D012106:Research / Q000639:trends